Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,4 MDP. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111072625A reveals a novel diatomite-catalyzed route for 3,4-methylenedioxyacetophenone, offering significant cost reduction and supply chain reliability for pharma intermediates.